Affiliation: National Imaging Facility, Australia

Dr. Yaser Hadi Gholami is a physicist specializing in nuclear medicine and conducts extensive research in nanomedicine, radionuclide therapy and imaging, radiation physics and biology, nuclear chemistry, and Monte Carlo simulation. In 2019, he developed a groundbreaking theory for positron annihilation localization using nanoscale magnetization during his time as a visiting research associate at Harvard University and Massachusetts General Hospital (MGH).

In 2020, he was honored with the prestigious 2020 Physics Grand Challenges award for his work on a quantum-medicine platform to study the quantum properties of cancer cells through positronium lifetime spectroscopy. Dr. Gholami's collaborations with Harvard Medical School and MGH have led to a novel chelate-free nanoparticle radiolabelling technique for PET/MR imaging and radionuclide therapy.

He has collaborated with OncoSil Medical Company to develop personalized 32P microparticle therapy and contributed to achieving IDE approval. Additionally, in partnership with Varian, he has established a radiobiological modeling platform to gain valuable insights into temporal changes in tumor FDG distribution and tumor cell radiosensitivity.